Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

ZBTB7A Loss Promotes Synthesis of Lipids and Ketone Bodies in Myeloid Leukemia

Vanessa C. Arfelli, Werner Schmitz, Martin E. Kirmaier, Enric Redondo Monte, Paul Kerbs, Monica Cusan, Sebastian Theurich, Christian Wichmann, Philipp A. Greif

Blood (2023) 142 (Supplement 1): 1390.

https://doi.org/10.1182/blood-2023-185682

Published: 2023

Journal Articles

Distinct Temporal Dynamic Serum Metabolite Profiles Characterize Treatment Response and Early Toxicity after B-Cell Lymphoma Directed CAR-T-Cell Therapy

David M. Cordas dos Santos, Amar Hadzic, Martin E. Kirmaier, Werner Schmitz, Viktoria Blumenberg, Kai Rejeski, Veit L. Buecklein, Michael von Bergwelt-Baildon, Marion Subklewe, Sebastian Theurich

Blood (2023) 142 (Supplement 1): 2078.

https://doi.org/10.1182/blood-2023-186178

Published: 2023

Journal Articles

Density of the Spleen in Low-Dose CT Scans Is Associated with High-Risk Disease Features and Shorter Survival in Newly Diagnosed Multiple Myeloma Patients

David M. Cordas dos Santos, Paul Trinkner, Sophie Guenther, Michael Winkelmann, Wolfgang G. Kunz, Kai Rejeski, Marion Subklewe, Michael von Bergwelt, Sebastian Theurich

Blood (2022) 140 (Supplement 1): 4332–4333.

https://doi.org/10.1182/blood-2022-163091

Published: 2022

Journal Articles

Alterations of Human Bone Marrow Niche in Clonal Hematopoiesis and AML

Yana Dragieva, Maja Rothenberg-Thurley, Bianka Ksienzyk, Amar Hadzic, Alexander Paulus, Benjamin Tast, Maryam Kazerani, Marion Subklewe, Stephanie Schneider, Karsten Spiekermann, Sebastian Theurich, Klaus H. Metzeler, Maria Solovey, Frank Ziemann

Blood (2022) 140 (Supplement 1): 11430–11431.

https://doi.org/10.1182/blood-2022-167168

Published: 2022

Journal Articles

The CAR-Hematotox Score As a Prognostic Model of Toxicity and Response in Patients Receiving BCMA-Directed CAR-T for Relapsed/Refractory Multiple Myeloma

Kai Rejeski, Doris K. Hansen, Radhika Bansal, Pierre Sesques, Sikander Ailawadhi, Jennifer M. Logue, Ciara L. Freeman, Melissa Alsina, Sebastian Theurich, Frederick L. Locke, Emmanuel Bachy, Michael D. Jain, Yi Lin, Marion Subklewe

Blood (2022) 140 (Supplement 1): 7506–7508.

https://doi.org/10.1182/blood-2022-165266

Published: 2022

Journal Articles

Body Composition and Immunonutritional Status Impact Survival Outcomes after CD19 CAR T-Cell Therapy

Kai Rejeski, David M. Cordas dos Santos, Paul Trinkner, Sophie Guenther, Lian Liu, Michael Winkelmann, Veit L Buecklein, Viktoria Blumenberg, Christian Schmidt, Philipp Karschnia, Wolfgang G. Kunz, Michael von Bergwelt, Sebastian Theurich, Marion Subklewe

Blood (2022) 140 (Supplement 1): 10405–10406.

https://doi.org/10.1182/blood-2022-159493

Published: 2022

Journal Articles

T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals

Blood (2022) 140 (10): 1104–1118.

https://doi.org/10.1182/blood.2022015956

Published: 2022

Includes: Supplemental data

Journal Articles

Treatment-Free Intervals during CD19xCD3 BiTE ® Construct-Mediated T-Cell Stimulation Induce Functional Reinvigoration and Transcriptional Reprogramming of Exhausted T Cells

Blood (2021) 138 (Supplement 1): 513.

https://doi.org/10.1182/blood-2021-150178

Published: 2021

Journal Articles

CD33 BiTE ® Construct Mediated Immunological Synapse Formation and Downstream Signaling in T Cells Is Dependent on Expression of Costimulatory Molecules on Target Cells

Anetta Marcinek, Bettina Brauchle, Gerulf Hänel, Sonja M Lacher, Nora Zieger, Roman Kischel, Michael von Bergwelt, Karsten Spiekermann, Sebastian Theurich, John R James, Veit L Buecklein, Marion Subklewe

Blood (2021) 138 (Supplement 1): 2237.

https://doi.org/10.1182/blood-2021-146488

Published: 2021

Journal Articles

Treatment-Free Intervals Mitigate T-Cell Exhaustion Induced By Continuous CD19xCD3-BiTE® Construct Stimulation in Vitro

Nora Zieger, Alyssa Nicholls, Jan Wulf, Gerulf Hänel, Maryam Kazerani Pasikhani, Veit Buecklein, MD, Bettina Brauchle, Anetta Marcinek, Daniel Nixdorf, Lisa Rohrbacher, Michaela Scheurer, Roman Kischel, MD, Karsten Spiekermann, MD, Oliver Weigert, MD, Sebastian Theurich, MD, Michael von Bergwelt, MD PhD, Marion Subklewe, MD

Blood (2020) 136 (Supplement 1): 44–45.

https://doi.org/10.1182/blood-2020-137421

Published: 2020

Journal Articles

Loss of ZBTB7A Enhances Glycolysis and Beta Oxidation in Myeloid Leukemia

Enric Redondo Monte, MSc, BSc, Anja Wilding, MSc, Georg Leubolt, MSc, Paul Kerbs, MSc, Johannes Bagnoli, Wolfgang Hiddemann, MD PhD, Wolfgang Enard, PhD, Sebastian Theurich, MD, Philipp A. Greif, MD PD

Blood (2019) 134 (Supplement_1): 1453.

https://doi.org/10.1182/blood-2019-128378

Published: 2019

Journal Articles

Obesity Negatively Impacts Outcome in Female Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Fludarabine, Cyclophosphamide and Rituximab (FCR): An Analysis of Three Phase III Studies of the German CLL Study Group (GCLLSG)

Blood (2018) 132 (Supplement 1): 4429.

https://doi.org/10.1182/blood-2018-99-113257

Published: 2018

Journal Articles

Human CD21 low CD86 pos B Cells Are Potent Antigen Presenting Cells, Which Are Expanded in Inflammatory Conditions

Alexander Shimabukuro-Vornhagen, MD, María Alejandra García-Márquez, PhD, Rieke N. Fischer, Juliane Iltgen-Breburda, Anne Fiedler, Kerstin Wennhold, PhD, Gunter Rappl, Hinrich Abken, Pia Hartmann, Clara Lehmann, Thomas Koslowsky, Marco Herling, MD, Dirk Beutner, Dominik Wolf, MD, Gerd Fätkenheuer, Andrea Rubbert-Roth, Michael Hallek, MD, Sebastian Theurich, Michael von Bergwelt-Baildon, Prof. Dr. Dr.

Blood (2015) 126 (23): 3432.

https://doi.org/10.1182/blood.V126.23.3432.3432

Published: 2015

Journal Articles

p38 MAPK Controls Sensitivity Towards BH3 Mimetics By Regulating Mcl-1 Expression of Chronic Lymphocytic Leukemia in Hypoxia and Acquired Resistance

Malte F Huelsemann, Michaela Patz, PhD, Laura Beckmann, Kerstin Brinkmann, Teresa Otto, Joachim Fandrey, MD, Hans Jiro Becker, Sebastian Theurich, MD, Michael S. von Bergwelt-Baildon, MD PhD, Christian P. Pallasch, MD, Réne P. Zahedi, Hamid Kashkar, PhD, Christian Reinhardt, MD, Michael Hallek, MD, Clemens-Martin Wendtner, MD, Lukas P. Frenzel, MD

Blood (2014) 124 (21): 1947.

https://doi.org/10.1182/blood.V124.21.1947.1947

Published: 2014

Journal Articles

The CD21 low B Cell Population Is Composed of an Anergic and an Immunostimulatory Germinal Center-like B Cell Subset

Alexander Shimabukuro-Vornhagen, MD, María García Márquez, Rieke Fischer, MD, Kerstin Wennhold, Juliane Iltgen, Sebastian Theurich, MD, Michael S. von Bergwelt-Baildon, MD PhD

Blood (2014) 124 (21): 1425.

https://doi.org/10.1182/blood.V124.21.1425.1425

Published: 2014

Journal Articles

Flamsa Reduced-Intensity Conditioning Regimen in AML Patients – Role of Re-Induction and Disease State Prior to Transplant

Udo Holtick, MDPhD, Alexander Shimabukuro-Vornhagen, MD, Geothy Chakupurakal, MBBS, MRCPath, PhD, Sebastian Theurich, MD, Silke Leitzke, Dominik Wolf, MD, Michael Hallek, MD, Michael S. von Bergwelt-Baildon, MD PhD, Christof Scheid, MDPhD, Jens Chemnitz, MD

Blood (2014) 124 (21): 3904.

https://doi.org/10.1182/blood.V124.21.3904.3904

Published: 2014

Journal Articles

Increased Functional T Cell Defects in Patients with low CD4 Counts after Allogeneic Hematopoietic Stem Cell Transplantation

Udo Holtick, MD PhD, Lukas P. Frenzel, MD, Shimabukuro-Vornhagen Alexander, MD, Sebastian Theurich, MD, Julia Claasen, Christof Scheid, MD, PhD, Michael von-Bergwelt-Baildon, MD PhD, Michael Hallek, MD PhD, Clemens Wendtner, MD, Jens M. Chemnitz, MD

Blood (2013) 122 (21): 4588.

https://doi.org/10.1182/blood.V122.21.4588.4588

Published: 2013

Journal Articles

CD30-Targeted Therapy with Brentuximab Vedotin Combined with Donor Lymphocyte Infusions Induce Sustained Clinical Remissions and Tumor Specific Immunity in a Series of Patients with Relapsed Hodgkin Lymphoma After Allogeneic Stem Cell Transplantation

Sebastian Theurich, MD, Joke Malcher, Kerstin Wennhold, Alexander Shimabukuro-Vornhagen, MD, Jens M. Chemnitz, MD, Holtick Udo, MD, Anke Krause, MD, Carsten Kobe, MD, Deniz Kahraman, MD, Chakupurakal Geothy, Andreas Engert, MD PhD, Scheid Christof, MD, Michael Hallek, MD PhD, Michael von Bergwelt-Baildon, MD, PhD

Blood (2012) 120 (21): 4213.

https://doi.org/10.1182/blood.V120.21.4213.4213

Published: 2012

Journal Articles

Impact of Hypoxia As Novel Microenvironmental Factor On Drug Susceptibility of Primary CLL Cells

Malte Huelsemann, Lukas P. Frenzel, MD, Dunja Baatout, M.Sc., Julia Claasen, Sebastian Theurich, MD, Laurent Kintzelé, Hans Jiro Becker, Michaela Patz, PhD, Christian P. Pallasch, MD, Michael S. von Bergwelt-Baildon, MD, PhD, Michael Hallek, MD, Clemens-Martin Wendtner, MD

Blood (2012) 120 (21): 3918.

https://doi.org/10.1182/blood.V120.21.3918.3918

Published: 2012

Journal Articles

Mast cells play a protumorigenic role in primary cutaneous lymphoma

Anja Rabenhorst, Max Schlaak, Lukas C. Heukamp, Anja Förster, Sebastian Theurich, Michael von Bergwelt-Baildon, Reinhard Büttner, Peter Kurschat, Cornelia Mauch, Axel Roers, Karin Hartmann

Blood (2012) 120 (10): 2042–2054.

https://doi.org/10.1182/blood-2012-03-415638

Published: 2012

Includes: Supplemental data

NARROW

ZBTB7A Loss Promotes Synthesis of Lipids and Ketone Bodies in Myeloid Leukemia

Distinct Temporal Dynamic Serum Metabolite Profiles Characterize Treatment Response and Early Toxicity after B-Cell Lymphoma Directed CAR-T-Cell Therapy

Density of the Spleen in Low-Dose CT Scans Is Associated with High-Risk Disease Features and Shorter Survival in Newly Diagnosed Multiple Myeloma Patients

Alterations of Human Bone Marrow Niche in Clonal Hematopoiesis and AML

The CAR-Hematotox Score As a Prognostic Model of Toxicity and Response in Patients Receiving BCMA-Directed CAR-T for Relapsed/Refractory Multiple Myeloma

Body Composition and Immunonutritional Status Impact Survival Outcomes after CD19 CAR T-Cell Therapy

T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals

Treatment-Free Intervals during CD19xCD3 BiTE ® Construct-Mediated T-Cell Stimulation Induce Functional Reinvigoration and Transcriptional Reprogramming of Exhausted T Cells

CD33 BiTE ® Construct Mediated Immunological Synapse Formation and Downstream Signaling in T Cells Is Dependent on Expression of Costimulatory Molecules on Target Cells

Treatment-Free Intervals Mitigate T-Cell Exhaustion Induced By Continuous CD19xCD3-BiTE® Construct Stimulation in Vitro

Loss of ZBTB7A Enhances Glycolysis and Beta Oxidation in Myeloid Leukemia

Obesity Negatively Impacts Outcome in Female Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Fludarabine, Cyclophosphamide and Rituximab (FCR): An Analysis of Three Phase III Studies of the German CLL Study Group (GCLLSG)

Human CD21 low CD86 pos B Cells Are Potent Antigen Presenting Cells, Which Are Expanded in Inflammatory Conditions

p38 MAPK Controls Sensitivity Towards BH3 Mimetics By Regulating Mcl-1 Expression of Chronic Lymphocytic Leukemia in Hypoxia and Acquired Resistance

The CD21 low B Cell Population Is Composed of an Anergic and an Immunostimulatory Germinal Center-like B Cell Subset

Flamsa Reduced-Intensity Conditioning Regimen in AML Patients – Role of Re-Induction and Disease State Prior to Transplant

Increased Functional T Cell Defects in Patients with low CD4 Counts after Allogeneic Hematopoietic Stem Cell Transplantation

CD30-Targeted Therapy with Brentuximab Vedotin Combined with Donor Lymphocyte Infusions Induce Sustained Clinical Remissions and Tumor Specific Immunity in a Series of Patients with Relapsed Hodgkin Lymphoma After Allogeneic Stem Cell Transplantation

Impact of Hypoxia As Novel Microenvironmental Factor On Drug Susceptibility of Primary CLL Cells

Mast cells play a protumorigenic role in primary cutaneous lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only